RetiVue has received $1,500,000 Phase II funding from the National
Eye Institute/National Institutes of Health for continued development
of the RetiVue WF.
During Phase II of our development, we are creating a functioning prototype of the RetiVue WF. Once achieved, this will demonstrate that all technical hurdles have been surpassed and that the device can be prepared for commercialization.
The Virginia Center for Innovative Technology has provided RetiVue, LLC with $50,000 to support additional hardware and software development for the RetiVue WF camera.
RetiVue has received $225,000 Phase I funding from the National
Eye Institute/National Institutes of Health to develop a
handheld camera suitable for retinopathy of prematurity (ROP)
and universal newborn eye screening. The RetiVue WF will be an
affordable, high resolution, hand-held device that connects to
any tablet wirelessly to allow wide-field imaging of the retina
for easily diagnosing and screening for ROP.
Work completed during this Phase I project, in addition to subsequent clinical testing, will lay the technical foundation onto which the world's first simple-to-manufacture, affordable, highly portable, and easy-to-use ROP screening device can be commercialized.
We are pleased to announce that RetiVue, LLC has been awarded a
$250,000 investment from the Virginia Center for Innovative
Technology as part of the Commonwealth Research Commercialization
Fund. This investment will be used to significantly advance
beta-prototype development of our CAVCAM imaging technology and
further pursue commercialization and clinical implementation
efforts in Virginia.
To read the official press release from the Virginia Center for Innovative Technology, please visit http://www.prweb.com/releases/2011/12/prweb!9053447.htm
The Commonwealth Research Commercialization Fund (CRCF) advances science- and technology-based research, development, and commercialization to drive economic growth in Virginia and to encourage collaboration among its institutions of higher education and partnerships between these colleges and universities and business and industry.
Please visit this page to keep up-to-date on any new developments regarding the CAVCAM prototype, collaborating partners, future investments, and additions to the RetiVue executive team and advisory board.
Below you can find earlier articles written about our technology and our team at the University of Virginia before RetiVue was founded. We hope you enjoy reading them!